Zusammenfassung
Es kann geschätzt werden, dass etwa 2 von 10.000 Neugeborenen oder 1–2 Neugeborene pro 1 Mio. Einwohner jährlich auf eine Lebertransplantation angewiesen sein werden.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsLiteratur
Literatur zu Abschn. 19.1
Arora-Gupta N, Davies P, McKiernan P, Kelly DA (2004) The effect of long-term calcineurin inhibitor therapy on renal function in children after liver transplantation. Pediatr Transplantation 8: 145–150
Brinkert F, Kemper MJ, Briem-Richter A et al. (2011) High prevalence of renal dysfunction in children after liver transplantation: non-invasive diagnosis using a cystatin C-based equation. Nephrol Dial Transplant 26: 1407–1412
Broering DC, Mueller L, Ganschow R et al. (2001) Is there still a need for living-related liver transplantation in children? Ann Surg 234: 713–722
Bucuvalas JC, Ryckman FC (2002) Long-term outcome after liver transplantation in children. Pediatr Transplantation 6: 30–36
Burdelski M, Nolkemper D, Ganschow R et al. (1999) Liver transplantation in children: Long-term outcome and quality of life. Eur J Pediatr 158(Suppl 2): S34–S42
Fine RN (2002) Growth following solid-organ transplantation. Pediatr Transplantation 6: 47–52
Ganschow R (Hrsg) (2003) Immunsuppression in der pädiatrischen Transplantationsmedizin. Uni-Med, Bremen
Ganschow R, Nolkemper D, Helmke K et al. (2000) Intensive care management after pediatric liver transplantation: a single center experience. Pediatr Transplantation 4: 273–279
Ganschow R, Broering DC, Nolkemper D (2001a) Th2 cytokine profile in infants predisposes to improved graft acceptance after pediatric liver transplantation. Transplantation 72: 929–934
Ganschow R, Broering DC, Stuerenburg I et al. (2001b) First experience with basiliximab in pediatric liver graft recipients. Pediatr Transplantation 5: 353–357
Ganschow R, Grabhorn E, Helmke K, Rogiers X, Burdelski M (2001c) Liver transplantation in children with Alagille Syndrome. Transpl Proc 33: 3608–3609
Ganschow R, Schulz T, Meyer T, Broering D, Burdelski M (2004) Low-dose immunosuppression reduces the incidence of posttransplant lymphoproliferative disease in pediatric liver graft recipients. J Pediatr Gastroenterol Nutr 38: 198–203
Grabhorn E, Schulz A, Helmke K et al. (2004) Short- and long-term results of liver transplantation in infants aged less than 6 months. Transplantation 78: 235–241
Halme L, Hoeckerstedt K, Lautenschlager I (2003) Cytomegalovirus infection and development of biliary complications after liver transplantation. Transplantation 75: 1853–1858
Kaller T,Langguth N, Ganschow R et al. (2010) Attention and executive functioning deficits in liver transplanted children. Transplantation 90: 1567–1573
Kelly DA (2001) Optimal immunosuppression in teenagers. Pediatr Transplantation 6: 480–487
Kovarik J, Mueller E, Bree JV et al. (1994) Cyclosporine pharmakokinetics and variability from a microemulsion formulation – a multicenter investigation in kidney transplant patients. Transplantation 58: 444–448
Martin SR, Atkison P, Anand R, Lindblad AS and the SPLIT Research Group (2004) Studies of pediatric liver transplantation 2002: patient and graft survival and rejection in pediatric recipients of a first liver transplant in the United States and Canada. Pediatr Transplantation 8: 273–283
Mazariegos GV, Reyes J, Webber SA et al. (2002) Cytokine gene polymorphisms in children successfully withdrawn from immunosuppression after liver transplantation. Transplantation 73: 1342–1346
Meyer-Koenig U, Weidmann M, Kirste G, Hufert FT (2004) Cytomegalovirus infection in organ-transplant recipients: diagnostic value of pp65 antigen test, qualitative polymerase chain reaction (PCR) and qualitative taqman PCR. Transplantation 77: 1692–1698
Roberts JP, Hulbert-Shearon TE, Merion RM, Wolfe RA, Port FK (2004) Influence of graft type on outcomes after pediatric liver transplantation. Am J Transplantation 4: 373–377
Schulz KH, Wein C, Boeck A, Rogiers X, Burdelski M (2003) Cognitive performance of children who have undergone liver transplantation. Transplantation 75: 1236–1240
Spada M, Silvia R, Maggione G et al. (2009) Pediatric liver transplantation. World J Gasroenterol 15(6): 648–674
Starzl TE (1969) Experience in hepatic transplantation. Saunders, Philadelphia
Whittington PF, Alonso EM, Superina RA, Freese DK (2002) Liver transplantation in children. J Pediatr Gastroenterol Nutr 35: S44–S50
Literatur zu Abschn. 19.2
Arya R, Gulati S, Deopujari S (2010) Management of hepatic encephalopathy in children. Postgrad Med J 86: 34–41
Baliga P, Alvarez S, Lindblad A, Zeng L (2004) Posttransplant survival in pediatric fulminant hepatic failure: the SPLIT experience. Liver Transpl 10: 1364–1371
Baquerizo A, Anselmo D, Shackleton C et al. (2003) Phosphorus as an early predictive factor in patients with acute liver failure. Transplantation 75: 2007–2014
Bhaduri BR, Mieli-Vergani G (1996) Fulminant hepatic failure: pediatric aspects. Semin Liver Dis 16: 349–355
Brockstedt M, Giani G, Herzig P et al. (1997) ESPED-Jahresbericht 1996. Monatsschr Kinderheilkd 145: 1228–1233
Carpentier B, Gautier A, Legallais C (2009) Artificial and bioartificial liver devices: present and future. Gut 58: 1690–1702 Melter M, Rodeck B, Brodehl J (1996) Akutes Leberversagen im Kindesalter. Monatsschr Kinderheilkd 144: 592–598
Chan G, Taqi A, Marotta P et al. (2009) Long-term outcomes of emergency liver transplantation for acute liver failure. Liver Transpl 15: 1696–1702
DeVictor D, Desplanques L, Debray D et al. (1992) Emergency liver transplantation for fulminant liver failure in infants and children. Hepatology 16: 1156–1162
Ekiz F, Yuksel I, Kertmen N, Yuksel O (2010) Liver toxicity due to broccoli juice. Eur J Gastroenterol Hepatol 22: 898
Faraj W, Dar F, Bartlett A et al. (2010) Auxiliary liver transplantation for acute liver failure in children. Ann Surg 251: 351–356
Gregory B, Larson AM, Reisch J, Lee WM (2010) Acetaminophen dose does not predict outcome in acetaminophen-induced acute liver failure. J Investig Med 58: 707–710
Grothues D, Strassburg A, Knoppke B et al. (2003) Riesenzellhepatitis in Assoziation mit autoimmunhämolytischer Anämie und Immunthrombopenie – Erfolgreiche Remissionserhaltung unter einer Therapie mit Mycophenolat Mofetil (MMF). In: Behrens R, Deutsch J (Hrsg) Symposia Abstracts. sps Publications, Eustis/USA, p 92
Harrison PM, Wendon JA, Gimson AE, Alexander GJ, Williams R (1991) Improvement by acetylcysteine of hemodynamics and oxygen transport in fulminant hepatic failure. N Engl J Med 324: 1852–1857
Kamat P, Kunde S, Vos M et al. (2012) Invasive intracranial pressure monitoring is a useful adjunct in the management of severe hepatic encephalopathy associated with pediatric acute liver failure. Pediatr Crit Care Med 13: e33–e38
Khuroo MS, Kamili S (2003) Aetiology and prognostic factors in acute liver failure in India. J Viral Hepat 10: 224–231.
Kneiseler G, Bachmann HS, Bechmann LP et al. (2010) A rare case of propofol-induced acute liver failure and literature review. Case. Rep Gastroenterol 4: 57–65
Knoppke B, Grothues D, Vermehren J et al. (2011) Auxiliary liver transplantation in 2 children with acute liver failure. Transpl Int 24: 40
Lee WM, Squires RH Jr, Nyberg SL, Doo E, Hoofnagle JH (2008) Acute liver failure: summary of a workshop. Hepatology 47: 1401–1415
Mahler H, Pasi A, Kramer JM et al. (1997) Fulminant liver failure in association with the emetic toxin of Bacillus cereus. N Engl J Med 336: 1142–1148
Melter M, Rodeck B, Kardorff R (1995) Liver transplantation for fulminant liver failure in childhood. Liver Transpl Surg 1: 5
Melter M, Nashan B, Strassburg A et al. (2002) Die pädiatrische Lebertransplantation – Indikationen und Ergebnisse. TransplantLinc 4: 54–62
Muller T, Langner C, Fuchsbichler A et al. (2004) Immunohistochemical analysis of Mallory bodies in Wilsonian and non-Wilsonian hepatic copper toxicosis. Hepatology 39: 963–969
Nguyen NT, Vierling JM (2011) Acute liver failure. Curr Opin Organ Transplant 16: 289–296
O'Grady JG, Alexander GJM, Hayllar KM, Williams R (1989) Early indicators of prognosis in fulminant hepatic failure. Gastroenterol 97: 439–445
Ozturk Y, Berktas S, Soylu OB et al. (2010) Fulminant hepatic failure and serum phosphorus levels in children from the western part of Turkey. Turk J Gastroenterol 21: 270–274
Posfay-Barbe KM, Schrenzel J, Frey J et al. (2008) Food poisoning as a cause of acute liver failure. Pediatr Infect Dis J 27: 846–847
Ringe H, Varnholt V, Zimmering M et al. (2011) Continuous veno-venous single-pass albumin hemodiafiltration in children with acute liver failure. Pediatr Crit Care Med 12: 257–264
Rudnick DA, Dietzen DJ, Turmelle YP et al. (2009) Serum alpha-NH-butyric acid may predict spontaneous survival in pediatric acute liver failure. Pediatr Transplant 13: 223–230
Schaefer B, Schaefer F, Engelmann G et al. (2011) Comparison of Molecular Adsorbents Recirculating System (MARS) dialysis with combined plasma exchange and haemodialysis in a children with acute liver failure. Nephrol Dial Transplant 26: 3633–3639
Shanmugam NP, Dhawan A (2011) Selection criteria for liver transplantation in paediatric acute liver failure: the saga continues. Pediatr Transplant 15: 5–6
Stickel F, Patsenker E, Schuppan D (2005) Herbal hepatotoxicity. J Hepatol 43: 901–910
Thomson M, McKiernan P, Buckels J, Mayer D, Kelly D (1998) Generalised mitochondrial cytopathy is an absolute contraindication to orthotopic liver transplant in childhood. J Pediatr Gastroenterol Nutr 26: 478–481
Vickers C, Neuberger J, Buckels J, McMaster P, Elias E (1988) Transplantation of the liver in adults and children with fulminant hepatic failure. J Hepatol 7: 143–150 (1988).
Vogel A, Heinrich E, Bahr MJ et al. (2004) Long-term outcome of liver transplantation for autoimmune hepatitis. Clin Transplant 18: 62–69
Literatur zu Abschn. 19.3
Alcorn J, McNamara (2002) Ontogeny of hepatic and renal systemic clearance pathways in infants. Clin Pharmacokinet 41: 959–998
Alonso EA, Superina RA, Whitington PF (1999) Fulminant hepatitis and acute liver failure. In: Kelly DA (ed) Diseases of the liver and biliary system in children. Blackwell, Oxford, pp 77–94
Balistreri WF, Stocker JT (1990) Pediatric hepatology. Hemisphere, New York
Bass NM (2000) Toxic and drug-induced liver disease. In: Goldman L, Bennett JC (eds) Cecil textbook of medicine. Saunders, Philadelphia, pp 779–783
Bijleveld CMA (1993) Toxic hepatitis. In: Buts J-P, Sokal EM (eds) Management of digestive and liver disorders in infants and children. Elsevier, Amsterdam, pp 595–601
Bouwmeester NJ, Anderson BJ, Tibboel D, Holford NH (2004) Developmental pharmacokinetics of morphine and its metabolites in neonates, infants and young children. Br J Anaesth 92: 208–217
Colon AR (1990) Textbook of pediatric hepatology. Year Book, Chicago
Dienstag JL, Isselbacher KJ (2001) Toxic and drug-induced hepatitis. In: Braunwald E, Fauci AS, Hauser SL et al. (eds) Harrison’s principles of internal medicine. McGraw-Hill, New York, pp 1737–1742
Fakhoury M, Jacqz-Aigrain E (2005) Developmental pharmacogenetics. Paediatrica 16: 28–31
Gregus Z, Klaassen CD (1998) Hepatic disposition of xenobiotics during prenatal and early postnatal development. In: Polin RA, Fox WW (eds) Fetal and neonatal physiology. Saunders, Philadelphia, pp 1472–1493
Johnson TN (2003) The development of drug metabolizing enzymes and their influence on the susceptibility to adverse drug reactions in children. Toxicology 192: 37–48
Kearns GL, Abdel-Rahman SM, Alander SW et al. (2003) Developmental pharmacology – drug disposition, action and therapy in infants and children. N Engl J Med 349: 1157–1167
Lacroix D, Sonnier M, Moncion A, Cheron G, Cresteil T (1997) Expression of CYP3 A in the human liver – evidence that the shift between CYP3A7 and CYP3A4 occurs immediately after birth. Eur J Biochem 247: 625–634
Mowat AP (1994) Liver disorders in childhood. Butterworth-Heinemann, Oxford
Roberts EA (2007) Drug-induced liver disease. In: Suchy J, Sokol RJ, Balistreri WF (eds) Liver disease in children, 3rd edn. Cambridge University Press, Cambridge, pp 478–512
Stricker BHC, Spoelstra P (1985) Drug-induced hepatic injury. Elsevier, Amsterdam
Zakim D, Boyer TD (2003) Hepatology. A textbook of liver disease. Saunders, Philadelphia
Zhang-Xu L, Govindarajan S, Kaplowitz N (2004) Innate immune system plays a critical role in determining the progression and severity of acetaminophen hepatotoxicity. Gastroenterology 127: 1760–1774
Zimmerman HJ, Ishak KG (2002) Hepatic injury due to drugs and toxins. In: MacSween RNM, Ishak KG, Burt AD et al. (eds) Pathology of the liver. Churchill Livingstone, London, pp 621–709
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Ganschow, R., Melter, M., Deutsch, J. (2013). Lebertransplantation und Leberversagen. In: Rodeck, B., Zimmer, KP. (eds) Pädiatrische Gastroenterologie, Hepatologie und Ernährung. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-24710-1_19
Download citation
DOI: https://doi.org/10.1007/978-3-642-24710-1_19
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-24709-5
Online ISBN: 978-3-642-24710-1
eBook Packages: Medicine (German Language)